ArticleFrontiers in oncology2021

Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes.

Ashok K Pullikuth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.